Article
Feasibility of whole‐genome sequencing‐based tumor diagnostics in routine pathology practice
6 Jul 2022
Abstract excerpt
The current increase in number and diversity of targeted anticancer agents poses challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in underdiagnosis and treatment. Whole-genome sequencing (WGS) may provide a sustainable solution for addressing current as well as future diagnostic challenges. The present study therefore aimed to prospectively assess feasibility, validity, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
